Documents Hepatitis web study Hepatitis web study Ledipasvir-Sofosbuvir +/- 3 rd DAA in HCV Genotype 1 NIAID.....

Slide 1 Hepatitis web study Hepatitis web study Ledipasvir-Sofosbuvir +/- 3 rd DAA in HCV Genotype 1 NIAID SYNERGY Phase 2 Treatment Naïve (unfavorable baseline treatment…

Documents Ledipasvir-Sofosbuvir +/- 3 rd DAA in HCV Genotype 1 SYNERGY

PowerPoint Presentation Ledipasvir-Sofosbuvir +/- 3rd DAA in HCV Genotype 1 NIAID SYNERGY: Genotype 1 Phase 2 Treatment Naïve (unfavorable baseline treatment characteristics)…

Documents Ledipasvir-sofosbuvir +/- 3 rd DAA in HCV Genotype 1 NIH SYNERGY

PowerPoint Presentation Ledipasvir-Sofosbuvir +/- 3rd DAA in HCV Genotype 1 NIH SYNERGY Phase 2 Treatment Naïve (unfavorable baseline treatment characteristics) Kohli…